Approval · Notice of Compliance 1651 · 1999
TEMOVATE: Notice of Compliance 1651
Issued May 28, 1999
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1651
- Date
- May 28, 1999
- Company
- Glaxo Wellcome Inc.Mississauga, Ontario, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Other
- Therapeutic class
- Topical corticosteroid
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TEMOVATE | 02240268 | — |
| TEMOVATE | 02240267 | — |
Medicinal ingredients
- CLOBETASOL PROPIONATE 0.05 PER